Our proprietary Artificial Cell Membrane (ACM) technology allows the production of high-quality functional membrane proteins (e.g., drug targets) in a native-like environment of engineered polymer membranes, without the need to use cells.

This robust technology enables development of novel and difficult protein targets for drug discovery, immunology, diagnostics and therapeutic development with a timeline that is considerably faster and more cost-effective than traditional techniques.
Please see our publications for more details.